Benzodiazepines are the most widely prescribed class of psychotropes. The demonstration of specific, high affinity binding sites for benzodiazepines in mammalian brain has provided a basis for a radioreceptor assay (RRA) of these compounds in biological samples (fluids or tissues). The RRA permits the simultaneous measurement of the benzodiazepine molecules that bind to the receptor, providing a total estimate of all pharmacologically active forms of the drug, which is useful in drug monitoring and in the intensive care of patients. After a complete description of the methodological aspects of this technique, the results obtained in therapeutic monitoring and in toxicological analysis are reviewed, and the advantages and disadvantages of th...
Binding assays still form a fundamental part of modem drug development. Receptor binding assays are ...
Binding assays still form a fundamental part of modem drug development. Receptor binding assays are ...
N-0437 is a recently developed dopamine (D2) agonist, theoretically attractive in the therapy of Par...
The clinical monitoring and intensive care of patients who have taken an overdose of a benzodiazepin...
In this paper the applicability ot radioreceptor assays tor systematic toxicological analysis will b...
In this paper the applicability ot radioreceptor assays tor systematic toxicological analysis will b...
Radioreceptor assays can be a useful tool for systematic toxicological analysis in that they can be ...
Radioreceptor assay and radioimmunoassay of selected benzodiazepines in urine samples from racing gr...
In this article, an improved benzodiazepine radioreceptor assay is described, which allows substanti...
Radioreceptor assays can be developed for every class of drugs whose pharmacological action is media...
Central-type benzodiazepine binding sites were characterized in a single normal human subject, using...
Using 11C-labeled Ro15-1788 and positron emission tomography, studies of benzodiazepine binding site...
Benzodiazepine drugs belong to important and most widely used medicaments. They demonstrate such the...
Binding assays still form a fundamental part of modem drug development. Receptor binding assays are ...
Binding assays still form a fundamental part of modem drug development. Receptor binding assays are ...
N-0437 is a recently developed dopamine (D2) agonist, theoretically attractive in the therapy of Par...
The clinical monitoring and intensive care of patients who have taken an overdose of a benzodiazepin...
In this paper the applicability ot radioreceptor assays tor systematic toxicological analysis will b...
In this paper the applicability ot radioreceptor assays tor systematic toxicological analysis will b...
Radioreceptor assays can be a useful tool for systematic toxicological analysis in that they can be ...
Radioreceptor assay and radioimmunoassay of selected benzodiazepines in urine samples from racing gr...
In this article, an improved benzodiazepine radioreceptor assay is described, which allows substanti...
Radioreceptor assays can be developed for every class of drugs whose pharmacological action is media...
Central-type benzodiazepine binding sites were characterized in a single normal human subject, using...
Using 11C-labeled Ro15-1788 and positron emission tomography, studies of benzodiazepine binding site...
Benzodiazepine drugs belong to important and most widely used medicaments. They demonstrate such the...
Binding assays still form a fundamental part of modem drug development. Receptor binding assays are ...
Binding assays still form a fundamental part of modem drug development. Receptor binding assays are ...
N-0437 is a recently developed dopamine (D2) agonist, theoretically attractive in the therapy of Par...